Home
Pharmaceuticals

Sector: Pharmaceuticals

BOTOX v PROTOX: Australia’s highest court issues its decision

The decision will likely increase the difficulties faced by trademark owners wishing to deter other traders from referencing their trademarks.

Retailers hit hard as economic conditions return to volatility: WTR Brand Elite analysis

Stock markets returned to volatility in February. In contrast to January, when major indices rose in value, key markets fell last month.

Pharmaceuticals correspondent

Thought leadership from industry experts

Latest content

Only a few weeks left to make nominations for the 2021 WTR Industry Awards and WTR 300 projects

There's not long left to nominate corporate trademark professionals for recognition at the WTR Industry Awards 2021 and in the next edition of WTR 300: The World’s Leading Corporate Trademark Professionals.

23 November 2020

Brands and covid-19: trademark filing data reveals how businesses are cashing in on pandemic

Trademark applications relating to disinfectants, gloves and masks are on the increase, with Class 5 and Class 10 showing significant annual growth.

20 November 2020

Inclusion in the IP profession; removing formalities requirements; UKIPO on Brexit – INTA 2020 update

As the INTA 2020 Annual Meeting draws to a close, WTR presents observations from the numerous sessions that have taken place over the past few days.

19 November 2020

Navigating regulation and a crowded Class 5: the race to register a covid-19 vaccine

This week, The Telegraph reported on some of the likely contenders for Pfizer’s vaccine name based on trademark filings by the company and partner BioNTech.

18 November 2020

From the WTR archive: inside pharmaceutical brands

For our latest delve into WTR’s unrivalled archive of trademark content, we present a selection of articles focused on the IP issues faced by pharmaceutical companies.

14 November 2020

Artificial intelligence “insufficient” to prevent counterfeits on online marketplaces, study claims

A new study has looked at how automated systems are being used to detect and prosecute IP infringement online, with the academic behind the research telling WTR that the claim that such tools can detect counterfeits “is simply marketing hype”.

12 November 2020

The race for a covid-19 vaccine: a brand opportunity and risk for the entire pharmaceutical sector

The big news from Pfizer on its covid-19 vaccine candidate has brought optimism to many this week. In our latest opinion column we consider the brand dimensions of this breakthrough – for Pfizer and the wider pharmaceutical industry.

11 November 2020

Four new states legalise recreational cannabis: what it means for brands

US election changes to cannabis and hard drug laws alter the legal landscape, but questions remain as to how they open up the trademark market.

05 November 2020

Still time to nominate for the 2021 WTR Industry Awards and WTR 300 projects

There is still time to nominate corporate trademark professionals for recognition at the WTR Industry Awards 2021 and in the next edition of WTR 300.

26 October 2020

Fighting counterfeits during a pandemic, monetising brands and picking external counsel – takeaways from the second week of WTR Connect

The highlights from the second week of WTR Connect include insight into the record-breaking filing levels in key Asia-Pacific jurisdictions, how Microsoft’s tech philosophy spurs the trademark department and strategies to bring down enforcement costs.

16 October 2020

Unlock unlimited access to all WTR content